1. DNMT3A‐2 EXPRESSION LEVELS CHARACTERISE DIFFUSE LARGE B‐CELL LYMPHOMA WITH DISTINCT METHYLATION PATTERNS AND OUTCOME. (June 2017) Authors: Kuhnl, A.; Shaikh, R.; Cunningham, D.; Counsell, N.; Barrans, S.; Burton, C.; Bentley, M.; Gleeson, M.; Edwards, L.; Ulrich, L.; Smith, P.; Clifton‐Hadley, L.; Schofield, O.; Lawrie, A.; Linch, D.; Hubank, M.; Kaiser, M. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 154 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P1459: SAFETY AND EFFICACY FINDINGS OF AUTO1, A FAST-OFF RATE CD19 CAR, IN RELAPSED/REFRACTORY B-CELL NON-HODGKIN'S LYMPHOMA (B-NHL), AND CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) / SMALL LYMPHOCYTIC LYMPHOMA (SLL). (23rd June 2022) Authors: Roddie, C.; Dias, J.; O'Reilly, M.; Mitsikakou, M.; Charalambous, E.; Green, L.; Vaughan, M.; Agliardi, G.; Garcia, J.; Lewin, E.; Lowdell, M.; Marzolini, M.; Wood, L.; Holmes, H.; Ngai, Y.; Popova, B.; Wilson, W.; Kunaseelan, S.; Spanswick, V.; Lowe, H. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1341 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P1460: SAFETY AND EFFICACY FINDINGS OF AUTO1, A FAST-OFF RATE CD19 CAR, IN RELAPSED/REFRACTORY PRIMARY CNS LYMPHOMA. (23rd June 2022) Authors: Roddie, C.; Dias, J.; O'Reilly, M.; Green, L.; Vaughan, M.; Agliardi, G.; Garcia, J.; Lewin, E.; Lowdell, M.; Mitsikakou, M.; Charalambous, E.; Hotblack, A.; Dreau, H.; Marzolini, M.; Wood, L.; Every-Clayton, C.; Lal, A.; Ngai, Y.; Popova, B.; Malhi, A. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1342 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P404: PROGNOSTIC IMPACT OF CEBPA-MUTATIONAL SUBGROUPS IN ADULT AML – RESULTS OF A LARGE METAANALYSIS IN MORE THAN 1000 CEBPA-MUTANT PATIENTS. (23rd June 2022) Authors: Georgi, J.-A.; Stasik, S.; Kramer, M.; Röllig, C.; Haferlach, T.; Valk, P.; Linch, D.; Herold, T.; Duployez, N.; Taube, F.; Platzbecker, U.; Serve, H.; Baldus, C.; Müller-Tidow, C.; Haferlach, C.; Meggendorfer, M.; Koch, S.; Boertjes, E. L.; Hills, R. K.; Burnett, A. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 304 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. TARGETING THE T‐CELL RECEPTOR Β‐CONSTANT DOMAIN FOR IMMUNOTHERAPY OF T‐CELL MALIGNANCIES. (June 2017) Authors: Maciocia, P.M.; Wawrzyniecka, P.; Philip, B.; Ricciardelli, I.; Akarca, A.; Onohua, S.; Cole, D.; Sewell, A.; Peggs, K.; Linch, D.; Marafioti, T.; Pule, M. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 252 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗